Unicycive Therapeutics Announced Results From The Oxylanthanum Carbonate UNI-OLC-201 Pivotal Trial, Established Favorable Tolerability And Safety And New Drug Application Submission Anticipated In Q3 2024
Unicycive Therapeutics宣布来自氧兰素碳酸盐UNI-OLC-201关键试验的结果,证实其良好的耐受性和安全性,新药申请预计将在2024年第三季度提交。